In alkalosis, the enzyme systems of the body run below par, reducing blood pressure and pulse, contributing to:
Not exact matches
Among mechanically ventilated patients with chronic obstructive pulmonary disease (COPD) and metabolic
alkalosis, administration of the respiratory stimulant acetazolamide did not significantly reduce the duration of invasive mechanical ventilation, according to a study
in the February 2 issue of JAMA.
For the acetazolamide group (n = 187), compared with the placebo group (n = 193), no significant between - group differences were found for median duration of mechanical ventilation -LRB--16.0 hours), duration of weaning off mechanical ventilation -LRB--0.9 hours), or for other respiratory parameter - values (respiratory frequency, tidal volume, and minute ventilation), although daily changes of serum bicarbonate and number of days with metabolic
alkalosis decreased significantly more
in the acetazolamide group.
Acetazolamide has been used for decades as a respiratory stimulant for patients with COPD and metabolic
alkalosis (an increase
in the alkalinity of body fluids due to an increase
in alkali intake or a decrease
in acid concentration), but no large randomized placebo - controlled trial has been available to confirm this approach.
In contrast, there is a large range for both acidosis and for
alkalosis.
Metabolic
alkalosis only occurs
in people seriously ill.
Potassium deficiency is likely to cause
alkalosis (called Potassium Deficient Alkalosis) in mos
alkalosis (called Potassium Deficient
Alkalosis) in mos
Alkalosis)
in most people.
This is especially true if the diarrhea is also compounded by vomiting as this can lead to metabolic
alkalosis in dogs.
Loss of bicarbonate through the stool can lead to a condition called metabolic acidosis which is characterized by very rapid and very deep respirations
in an effort to compensate
in the loss of bicarbonate by inducing respiratory
alkalosis and bring the serum pH back to more normal levels.
GranuFlo Recall Help explains how this product was used
in hemodialysis; possible side effects including heart attack, stroke, and metabolic
alkalosis; news related to the recall; and how those hurt by the product may be eligible to file a lawsuit against GranuFlo's manufacturer.